When the eye isn’t getting enough oxygen in the face of common conditions like premature birth or diabetes, it sets in motion a state of frenzied energy production that can ultimately result in blindness, and
More than 200 genes with novel and known roles in glioblastoma—the most aggressive type of brain cancer—offer promising new drug targets. Researchers from the Wellcome Sanger Institute, Addenbrooke’s Hospital and their collaborators engineered a new
A team from Lawson Health Research Institute and Western University are the first in the world to profile the body’s immune response to COVID-19. By studying blood samples from critically ill patients at London Health
Cancer researchers at Children’s Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine, employing the
Scientists from the University of Manchester have identified parts of the SARS-CoV-2 strain of coronavirus that activate an immune response and which could act as targets for vaccine development. Writing in Annals of the Rheumatic
An analysis of 13,000 tumors highlights two previously overlooked genes as potential new therapeutic targets for cancer treatment. The researchers have also identified potential new therapeutic targets for male infertility. Both findings are the result
Western researchers have moved a step closer to identifying a ‘brain fingerprint’ for consciousness—a discovery that will unlock further understanding into why some patients, presumed to be vegetative, are still aware of the world them.
More than one-fifth of all human cancers harbor mutations in one of the members of the BAF chromatin remodeling complex. Deep biochemical and epigenomic characterization of a cell line panel comprehensively representing all these mutations
NHS could save £727MILLION over the next decade if all over-20s with type 2 diabetes kept their blood sugar, blood pressure and cholesterol in check Fewer than two in five patients meet targets to control
When Cellix Bio, a drug design firm, approached Dr. Rajesh Lalla to discuss ideas and their patented compounds for a better way to treat oral mucositis, he had no doubt he wanted to be involved.